These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 20338476)
1. Permanent prostate brachytherapy in prostate glands <20 cm(3). Mayadev J; Merrick GS; Reed JR; Butler WM; Galbreath RW; Allen ZA; Wallner KE Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1450-5. PubMed ID: 20338476 [TBL] [Abstract][Full Text] [Related]
2. Biochemical and functional outcomes following brachytherapy with or without supplemental therapies in men < or = 50 years of age with clinically organ-confined prostate cancer. Merrick GS; Wallner KE; Galbreath RW; Butler WM; Brammer SG; Allen ZA; Lief JH; Adamovich E Am J Clin Oncol; 2008 Dec; 31(6):539-44. PubMed ID: 19060584 [TBL] [Abstract][Full Text] [Related]
3. Monotherapeutic brachytherapy for clinically organ-confined prostate cancer. Merrick GS; Butler WM; Wallner KE; Galbreath RW; Adamovich E W V Med J; 2005; 101(4):168-71. PubMed ID: 16296198 [TBL] [Abstract][Full Text] [Related]
5. Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity. Allen ZA; Merrick GS; Butler WM; Wallner KE; Kurko B; Anderson RL; Murray BC; Galbreath RW Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):981-7. PubMed ID: 15989998 [TBL] [Abstract][Full Text] [Related]
6. Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer. Zelefsky MJ; Yamada Y; Cohen GN; Shippy A; Chan H; Fridman D; Zaider M Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):65-70. PubMed ID: 17189063 [TBL] [Abstract][Full Text] [Related]
7. Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy. Merrick GS; Butler WM; Wallner KE; Galbreath RW; Lief JH; Adamovich E Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1056-62. PubMed ID: 15001245 [TBL] [Abstract][Full Text] [Related]
8. Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity after permanent interstitial brachytherapy. Hinerman-Mulroy A; Merrick GS; Butler WM; Wallner KE; Allen Z; Adamovich E Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1367-82. PubMed ID: 15275722 [TBL] [Abstract][Full Text] [Related]
9. Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy. Corriveau J; Wallner K; Merrick G; True L; Cavanagh W; Sutlief S; Butler W Brachytherapy; 2003; 2(2):108-13. PubMed ID: 15062149 [TBL] [Abstract][Full Text] [Related]
10. Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalation. Vicini FA; Kestin LL; Martinez AA Tech Urol; 2000 Jun; 6(2):135-45. PubMed ID: 10798815 [TBL] [Abstract][Full Text] [Related]
11. Rectal function following brachytherapy with or without supplemental external beam radiation: results of two prospective randomized trials. Merrick GS; Butler WM; Wallner KE; Galbreath RW; Kurko B; Cleavinger S Brachytherapy; 2003; 2(3):147-57. PubMed ID: 15062137 [TBL] [Abstract][Full Text] [Related]
12. Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy. Stone NN; Potters L; Davis BJ; Ciezki JP; Zelefsky MJ; Roach M; Shinohara K; Fearn PA; Kattan MW; Stock RG Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):341-6. PubMed ID: 18597953 [TBL] [Abstract][Full Text] [Related]
13. Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy. Raben A; Rusthoven KE; Sarkar A; Glick A; Benge B; Jacobs D; Raben D Brachytherapy; 2009; 8(3):297-303. PubMed ID: 19213608 [TBL] [Abstract][Full Text] [Related]
14. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer. Konishi K; Yoshioka Y; Isohashi F; Sumida I; Kawaguchi Y; Kotsuma T; Adachi K; Morimoto M; Fukuda S; Inoue T Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1003-7. PubMed ID: 19345517 [TBL] [Abstract][Full Text] [Related]
15. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471 [TBL] [Abstract][Full Text] [Related]
16. The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry. Neill M; Studer G; Le L; McLean M; Yeung I; Pond G; Crook JM Brachytherapy; 2007; 6(3):173-9. PubMed ID: 17681239 [TBL] [Abstract][Full Text] [Related]
17. Outcomes following iodine-125 monotherapy for localized prostate cancer: the results of leeds 10-year single-center brachytherapy experience. Henry AM; Al-Qaisieh B; Gould K; Bownes P; Smith J; Carey B; Bottomley D; Ash D Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):50-6. PubMed ID: 20005453 [TBL] [Abstract][Full Text] [Related]